{
    "2019-06-05": [
        [
            {
                "time": "2018-09-28",
                "original_text": "Eli Lilly Takes Aim at Chronic Pain Problem, Alleviating Opiate Addiction",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "chronic pain",
                        "opiate addiction"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-09-28",
                "original_text": "Eli Lilly gets FDA approval for cluster headache medication",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "FDA approval",
                        "cluster headache"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-06-15",
                "original_text": "How Merck reached new ground in the fight against cancer",
                "features": {
                    "keywords": [
                        "Merck",
                        "cancer",
                        "new ground"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-06-04",
                "original_text": "The Daily Biotech Pulse: Curtains Down On ASCO, Rewalk Flies, Eli Lilly's Migraine Drug Approved For Cluster Headache",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "migraine drug",
                        "cluster headache",
                        "ASCO"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2019-06-10",
                "original_text": "Lilly to Showcase Scientific Innovation within Dermatology Portfolio at 24th World Congress of Dermatology",
                "features": {
                    "keywords": [
                        "Lilly",
                        "scientific innovation",
                        "dermatology"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-09-28",
                "original_text": "Eli Lilly's Emgality gets FDA approval for episodic cluster headaches",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Emgality",
                        "FDA approval",
                        "episodic cluster headaches"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-09-28",
                "original_text": "FDA Approves EmgalityÂ® (galcanezumab-gnlm) as the First and Only Medication for the Treatment of Episodic Cluster Headache that Reduces the Frequency of Attacks",
                "features": {
                    "keywords": [
                        "FDA",
                        "Emgality",
                        "episodic cluster headache",
                        "frequency of attacks"
                    ],
                    "sentiment_score": 0.95,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}